¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Pulmonary valve disorders"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • pulmonary surfactant
    ÆóÇ¥¸éȰ¼ºÁ¦, ÇãÆÄÇ¥¸éȰ¼ºÁ¦
  • pulmonary trunk
    Æóµ¿¸Æ, ÇãÆÄµ¿¸Æ
  • pulmonary tuberculosis
    Æó°áÇÙ
  • pulmonary vascular resistance
    ÆóÇ÷°üÀúÇ×
  • pulmonary ventilation
    Æóȯ±â
  • pulmonary ventilatory capacity
    Æóȯ±â¿ë·®
  • right pulmonary artery
    ¿À¸¥ÇãÆÄµ¿¸Æ, ¿ìÆóµ¿¸Æ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • pulmonary sound
    Æóµ¿¸ÆÀ½
  • pulmonary stenosis
    ÇãÆÄµ¿¸ÆÆÇ¸·ÇùÂø(Áõ), Æóµ¿¸ÆÆÇÇùÂø(Áõ)
  • pulmonary strongyloidiasis
    ÇãÆÄºÐ¼±ÃæÁõ, ÆóºÐ¼±ÃæÁõ
  • pulmonary surfactant
    ÇãÆÄ°è¸éȰ¼ºÁ¦, Æó°è¸éȰ¼ºÁ¦
  • pulmonary thromboembolism
    ÇãÆÄÇ÷Àü»öÀüÁõ, ÆóÇ÷Àü»öÀüÁõ
  • pulmonary trunk
    ÇãÆÄµ¿¸Æ
  • pulmonary tuberculosis
    Æó°áÇÙ
  • pulmonary vasculature
    ÇãÆÄ¸Æ°ü, Æó¸Æ°ü
  • pulmonary alveolar proteinosis
    Æó´Ü¹éÁõ, ÇãÆÄ²Ê¸®´Ü¹éÁõ
  • pulmonary artery wedge pressure
    Æóµ¿¸Æ½û±â¾Ð
  • pulmonary capillary wedge pressure
    ÇãÆÄ¸ð¼¼Ç÷°ü½û±â¾Ð, Æó¸ð¼¼Ç÷°ü½û±â¾Ð
  • pulmonary flow resistance
    Æó±â·ùÀúÇ×
  • pulmonary function test
    Æó±â´É°Ë»ç
  • pulmonary meniscus sign
    ÇãÆÄÃʽ´Þ¡ÈÄ, ÆóÃʽ´Þ¡ÈÄ
  • pulmonary perfusion scan
    ÇãÆÄ°ü·ù½ºÄµ, Æó°ü·ù½ºÄµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • primary pulmonary lobule
    ÀÏÂ÷ÇãÆÄ¼Ò¿±
  • proteinosis, pulmonary alveolar
    ´Ü¹é(Áú)Áõ(Ó±ÛÜ(òõ)ñø), ÆóÆ÷¼º(øËøààõ)
  • pulmonary
    ÆóÀÇ
  • pulmonary
    ÆóÀÇ(øË¡­)
  • pulmonary P
    Æó¼ºP ½ÉÀüµµ¿ë¾î .
  • pulmonary T
    Æó¼ºT ½ÉÀüµµ¿ë¾î .
  • pulmonary abscess
    Æó³ó¾ç(øËÒÛåË).
  • pulmonary acariasis
    ȸÃþÁõ(ȸÃþ¡­ñø)
  • pulmonary actinomycosis
    Æó¹æ¼±±ÕÁõ(øËÛ¯àÊжñø).
  • pulmonary alveolar microlithiasis
    ÆóÆ÷¹Ì¼®Áõ(øËøàÚ°à´ñø).
  • pulmonary alveolar microlithiasis
    ÆóÆ÷¹Ì¼®Áõ(øËøàÚ°à´ñø)
  • pulmonary alveolar proteinosis
    ÆóÆ÷´Ü¹éÁõ(øËøàÓ±ÛÜñø).
  • pulmonary alveolar proteinosis
    ÆóÆ÷´Ü¹éÁõ(øËøàÓ±ÛÜñø)
  • pulmonary alveolar proteinosis
    ÆóÆ÷´Ü¹éÁõ(øËøàÓ±ÛÜñø)
  • pulmonary alveolar tree
    ÇãÆÄ²Ê¸®¼ÛÀÌ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • ball valve
    ±¸»ó¹ëºê.
  • ball valve
    ±¸»ó¹ëºê(ϹßÑ- ),±¸»óÆÇ¸·(ϹßÑ÷ûد),±¸ÇüÆÇ¸·(Ϲû¡÷ûد)
  • ball valve action
    ±¸»ó¹ëºêÀÛ¿ë.
  • ball valve action
    ±¸»ó¹ëºê ÀÛ¿ë(ϹßÑ-íÂéÄ)
  • ball valve prosthesis
    ±¸ÇüÀΰøÆÇ.
  • ball valve prosthesis
    ±¸ÇüÀΰøÆÇ¸·(Ï­û¡ìÑÍï÷ûد)
  • ball valve thrombus
    ±¸ÇüÇ÷Àü.
  • ball valve thrombus
    ±¸ÇüÇ÷Àü(Ϲû¡úìîû)
  • bicuspid aortic valve
    ÀÌÆÇ¼º ´ëµ¿¸ÆÆÇ(ì£÷ûàõÓÞÔÑØæ÷û).
  • bicuspid valve
    ÀÌ÷ÆÇ¸·(ì£ôÓ÷ýد).
  • bicuspid valve
    ÀÌ÷ÆÇ.
  • bioprosthetic valve
    »ýüÀΰøÆÇ¸·(ßæô÷ìÑÍï÷ýد).
  • bulboventricular valve
    ÆØ´ë½É½ÇÆÇ¸·
  • check valve
    ý¹ßºê, ¿ª·ùÀúÁöÆÇ
  • check valve mechanism
    ý¹ëºê±â±¸(¡­±â±¸).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
DDRT diseases, disorders and related topics
DIMS disorders of initiating and maintaining sleep
DOC date of conception; deoxycholate; deoxycorticosterone; died of other causes; disorders of cornificat...
DOES disorders of excessive sleepiness
DSM dextrose solution mixture; Diagnostic and Statistical Manual [of Mental Disorders]; Diploma in Socia...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
ACD Anemia of chronic disorders
BLPD B cell lympho-proliferative disorders
CAMDEX Cambridge Mental Disorders of the Elderly Examination
CMPD Chronic myeloproliferative disorders
CDG Congenital Disorders of Glycosylation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pulmonary sulcus tumor
    Æó±¸ Á¾¾ç
  • pulmonary tuberculosis
    Æó °áÇÙ
  • pulmonary vasculature
    Æó ¸Æ°ü°è, Æó ¸Æ°ü ±¸Á¶
  • pulmonary wedge pressure
    Æó ¼â ±â¾Ð
  • restrictive pulmonary disease
    ±¸¼Ó¼º Æó Áúȯ
  • right inferior pulmonary vein
    ¾Æ·¡ ¿À¸¥ ÇãÆÄ Á¤¸Æ
  • right pulmonary artery
    ¿À¸¥ ÇãÆÄ µ¿¸Æ
  • surgically contructed systemic-pulmonary shunts
    ¿Ü°úÀûÀ¸·Î Çü¼ºÇØÁØ Àü½Å-Æó¼º ´Ü¶ô
  • total anomalous pulmonary venous connection
    ÀüÆó Á¤¸Æ ¿¬°á ÀÌ»ó, ÃÑ Æó Á¤¸Æ ȯ·ù ÀÌ»ó, Æó Á¤¸Æ ¿¬°á ÀÌ»ó
    1. Á¿ìÀÇ ¸ðµç Æó Á¤¸ÆµéÀÌ Á½ɹæ°ú ¿¬°áµÇÁö ¾Ê°í ºñÁ¤»óÀûÀÎ °æ·Î¸¦ °ÅÃÄ Ã¼Á¤¸ÆÀ¸·Î ¿¬°áµÇ´Â °Í. ȯÀÚ°¡ »ýÁ¸Çϱâ À§Çؼ­´Â ¹Ýµå½Ã ½É¹æ Áß°Ý °á¼ÕÁõÀÌ ÀÖ¾î¾ß ÇÏ¸ç Æó Á¤¸ÆÀÌ ¿¬°áµÇ´Â ºÎÀ§¿¡ µû¶ó ½ÉÀå »óºÎÇü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
infant nutrition disorders Malnutrition, occurring in infants ages 1 month to 24 months, which is due to insufficient intake of food, dietary nutrients, or a pathophysiologic condition which prevents the absorption and utilization of food. Growth and development are markedly affected.
(12 Dec 1998)
iron metabolism disorders Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization.
(12 Dec 1998)
ocular motility disorders Disorders of eye movement resulting from malfunction of the sensory-motor mechanism of the eye which leads to faulty alignment of the eyes and/or visual impairment.
(12 Dec 1998)
oesophageal motility disorders Disorders affecting the motor function of the upper or lower oesophageal sphincters, the oesophageal body, or a combination of these parts. The failure of the sphincters to maintain a tonic pressure may result in the impeding of the passage of food, regurgitation of food, or reflux of gastric acid into the oesophagus.
(12 Dec 1998)
opioid-related disorders Disorders related or resulting from abuse or mis-use of opioids.
(12 Dec 1998)
temporomandibular joint disorders A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and X-rays are often inadequate or non-specific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia.
(12 Dec 1998)
eating disorders A group of disorders characterised by physiological and psychological disturbances in appetite or food intake.
(12 Dec 1998)
tic disorders Sudden, rapid, recurrent, nonrhythmic, stereotyped motor movements or vocalizations. All forms of tics may be exacerbated by stress and attenuated during absorbing activities. They are distinguished from other types of abnormal movements that may accompany general medical conditions.
(12 Dec 1998)
elimination disorders Excretory-related psychiatric disorders usually diagnosed in infancy or childhood.
(12 Dec 1998)
endocrine disorders Disorders which involve the over-production or under-production of hormone substances from an endocrine gland. Some examples include diabetes, hypothyroidism, hyperthyroidism, hyperparathyroidism, Cushing's disease, Cushing's syndrome and acromegaly.
(27 Sep 1997)
factitious disorders Disorders characterised by physical or psychological symptoms that are not real, genuine, or natural.
(12 Dec 1998)
feeding and eating disorders of childhood Mental disorders related to feeding and eating that are usually diagnosed in infancy or early childhood.
(12 Dec 1998)
urination disorders Disorders in the frequency of urination, the volume of urine produced or eliminated, or the ability to retain or void urine in normal fashion.
(12 Dec 1998)
lactation disorders Disturbances of milk secretion in either sex, not necessarily related to pregnancy.
(12 Dec 1998)
language development disorders Failure to understand or speak the language at the expected age. Causal factors include slow maturation, hearing loss, brain injury, mental retardation and emotional disorders.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á